Expansion of hematopoietic stem cells for transplantation: current perspectives.

Authors:
Schuster JA; Stupnikov MR; Ma G; Liao W; Lai R and 2 more

Journal:
Exp Hematol Oncol

Publication Year: 2012

DOI:
10.1186/2162-3619-1-12

PMCID:
PMC3514093

PMID:
23210618

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabil…
Zhou W; Li S; Wang H and 8 more (2024) - Transparency Score: 4/6
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive …
Shen XT; Xie SZ; Zheng X and 17 more (2024) - Transparency Score: 4/6
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting c…
Zhao Q; Zong H; Zhu P and 4 more (2024) - Transparency Score: 3/6
Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, …
Liu J; Jiang P; Lu Z and 2 more (2024) - Transparency Score: 3/6
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.
Zhou L; Lu Y; Liu W and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"This work was supported by Grant Number K01CA163999 to JR Aguila from the NIH - National Cancer Institute."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025